Business & Finance Covidien to spin off pharma business Mass High Tech (Boston) Dec. 15, 2011 Affymax partner Takeda won’t commercialize anemia drug in Japan The Wall Street Journal Dec. 15, 2011 Government & Legal News Government issues rule to minimize drug-supply disruption Modern Healthcare (subscription required) Dec. 15, 2011 CMS rule would require device, […]
Month: December 2011
Business & Finance ISTA rejects $314M buyout offer from Valeant The Globe and Mail (Toronto) Dec. 16, 2011 Apricus buys Topotarget USA, cancer drug Totect San Diego Union-Tribune Dec. 16, 2011 Bausch & Lomb seeks partners in eye-drug market PharmaTimes (U.K.) Dec. 16, 2011 Alexza considers strategic options as regulators review Adasuve Bloomberg Dec. 16,
The call for real-world evidence is the “shot heard round the world” in this new decade of global healthcare. Skyrocketing healthcare costs, an unraveling state of global finance and unprecedented technological advances in medicine have both commercial and government payers looking for answers to what seems to be an age-old question: How do we reduce
The call for real-world evidence is the “shot heard round the world” in this new decade of global healthcare. Skyrocketing healthcare costs, an unraveling state of global finance and unprecedented technological advances in medicine have both commercial and government payers looking for answers to what seems to be an age-old question: How do we reduce